Understanding the Cardiovascular Effects of Incretin
Ji Sung Yoon (Yoon JS), Hyoung Woo Lee (Lee HW)
Diabetes Metab J. 2011;35(5):437-443.   Published online 2011 Oct 31     DOI: https://doi.org/10.4093/dmj.2011.35.5.437
Citations to this article as recorded by Crossref logo
Cardioprotective Effects of Glucagon-like Peptide-1 (9-36) Against Oxidative Injury in H9c2 Cardiomyoblasts: Potential Role of the PI3K/Akt/NOS Pathway
Narawat Nuamnaichati, Warisara Parichatikanond, Supachoke Mangmool
Journal of Cardiovascular Pharmacology.2022; 79(1): e50.     CrossRef
Comparisons of pleiotropic effects of SGLT2 inhibition and GLP-1 agonism on cardiac glucose intolerance in heart dysfunction
Belma Turan, Aysegul Durak, Yusuf Olgar, Erkan Tuncay
Molecular and Cellular Biochemistry.2022;[Epub]     CrossRef
Interrelations of components of metabolic syndrome with the level of the hormones involved in regulation of adipose tissue metabolism
A. Y. Babenko, G. A. Matveev, T. I. Alekseenko, I. V. Derevitskii, M. A. Kokina, E. V. Shlyakhto
"Arterial’naya Gipertenziya" ("Arterial Hypertension").2020; 25(6): 639.     CrossRef
Attenuation of carotid neointimal formation after direct delivery of a recombinant adenovirus expressing glucagon-like peptide-1 in diabetic rats
Soo Lim, Gha Young Lee, Ho Seon Park, Dong-Hwa Lee, Oh Tae Jung, Kim Kyoung Min, Young-Bum Kim, Hee-Sook Jun, Jang Hak Chul, Kyong Soo Park
Cardiovascular Research.2017; 113(2): 183.     CrossRef
Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes
Cristina Mega, Edite Teixeira-de-Lemos, Rosa Fernandes, Flávio Reis
Journal of Diabetes Research.2017; 2017: 1.     CrossRef
Letter: Economic Impact of Combining Metformin with Dipeptidyl Peptidase-4 Inhibitors in Diabetic Patients with Renal Impairment in Spanish Patients (Diabetes Metab J2015;39:74-81)
Hannah Seok
Diabetes & Metabolism Journal.2015; 39(2): 171.     CrossRef
Diuretic and Natriuretic Effects of Dipeptidyl Peptidase-4 Inhibitor Teneligliptin
Masao Moroi, Tetsuya Kubota
Journal of Cardiovascular Pharmacology.2015; 66(2): 159.     CrossRef
The Nonglycemic Actions of Dipeptidyl Peptidase-4 Inhibitors
Na-Hyung Kim, Taeyang Yu, Dae Ho Lee
BioMed Research International.2014; 2014: 1.     CrossRef
Tolerability, effectiveness and predictive parameters for the therapeutic usefulness of exenatide in obese, Korean patients with type 2 diabetes
Sun Ok Song, Kwang Joon Kim, Byung-Wan Lee, Eun Seok Kang, Bong Soo Cha, Hyun Chul Lee
Journal of Diabetes Investigation.2014; 5(5): 554.     CrossRef
The endothelium in diabetes: Its role in insulin access and diabetic complications
Cathryn M. Kolka, Richard N. Bergman
Reviews in Endocrine and Metabolic Disorders.2013; 14(1): 13.     CrossRef
Is GPR119 agonism an appropriate treatment modality for the safe amelioration of metabolic diseases?
Lauren M Cornall, Michael L Mathai, Deanne H Hryciw, Andrew J McAinch
Expert Opinion on Investigational Drugs.2013; 22(4): 487.     CrossRef
Effects of GLP-1 on Forearm Vasodilator Function and Glucose Disposal During Hyperinsulinemia in the Metabolic Syndrome
Manfredi Tesauro, Francesca Schinzari, Angelo Adamo, Valentina Rovella, Francesca Martini, Nadia Mores, Angela Barini, Dario Pitocco, Giovanni Ghirlanda, Davide Lauro, Umberto Campia, Carmine Cardillo
Diabetes Care.2013; 36(3): 683.     CrossRef
Effect of a Dipeptidyl Peptidase-IV Inhibitor, Des-Fluoro-Sitagliptin, on Neointimal Formation after Balloon Injury in Rats
Soo Lim, Sung Hee Choi, Hayley Shin, Bong Jun Cho, Ho Seon Park, Byung Yong Ahn, Seon Mee Kang, Ji Won Yoon, Hak Chul Jang, Young-Bum Kim, Kyong Soo Park, Alice Y. W. Chang
PLoS ONE.2012; 7(4): e35007.     CrossRef
Glucagon-like peptide 1 and cardiac cell survival
Susana Ravassa, Amaia Zudaire, Javier Díez
Endocrinología y Nutrición (English Edition).2012; 59(9): 561.     CrossRef
GLP-1 and cardioprotection: from bench to bedside
S. Ravassa, A. Zudaire, J. Diez
Cardiovascular Research.2012; 94(2): 316.     CrossRef
Saxagliptin improves glucose tolerance but not survival in a murine model of dilated cardiomyopathy
Arpita Kalla Vyas, Lauren B. Aerni-Flessner, Maria A. Payne, Attila Kovacs, Patrick Y. Jay, Paul W. Hruz
Cardiovascular Endocrinology.2012; 1(4): 74.     CrossRef
Péptido similar al glucagón tipo 1 y supervivencia de la célula cardiaca
Susana Ravassa, Amaia Zudaire, Javier Díez
Endocrinología y Nutrición.2012; 59(9): 561.     CrossRef